The colorectal cancer cell line CD133−SW620 expressed high levels (>50%) of ULBP3 (59.0 ± 2.6%, n = 3), and CD133+SW620 cells expressed moderate levels (20%–50%) of ULBP3 (22.0 ± 1.4%, n = 3). This evidence concerns the gene ULBP3 and colorectal cancer.